Article Top Ad
Reading Time: 2 minutes

LOS ANGELES–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24XENT&src=ctag” target=”_blank”gt;$XENTlt;/agt; lt;a href=”https://twitter.com/hashtag/ClassAction?src=hash” target=”_blank”gt;#ClassActionlt;/agt;–The
Schall Law Firm
, a national shareholder rights litigation firm,
announces the filing of a class action lawsuit against Intersect ENT,
Inc. (“Intersect” or “the Company”) (NASDAQ: XENT)
for violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and
Exchange Commission.

Investors who purchased the Company’s shares between August 1, 2018 and
May 6, 2019, inclusive (the “Class Period”), are encouraged to contact
the firm before July 15, 2019.

If you are a shareholder who suffered a loss, click
here to participate
.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of
the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA
90067, at 424-303-1964, to discuss your rights free of charge. You can
also reach us through the firm’s website at www.schallfirm.com,
or by email at [email protected].

The class, in this case, has not yet been certified, and until
certification occurs, you are not represented by an attorney. If you
choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading
statements to the market. Intersect failed to maintain the necessary
force of reimbursement representatives to ensure physicians’ access to
SINUVA, its sinus implant. This caused the Company’s sales force to
concentrate on helping with reimbursement as opposed to driving sales
growth. Physicians became less likely to adopt the Company’s products
due to transaction costs and delays in reimbursement. Intersect
eventually hired staff to address these issues. Based on these facts,
the Company’s public statements were false and materially misleading
throughout the class period. When the market learned the truth about
Intersect, investors suffered damages.

Join
the case
to recover your losses.

The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder rights
litigation.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and rules of ethics.

Contacts

The Schall Law Firm
Brian Schall, Esq.
Sherin Mahdavian, Esq.
www.schallfirm.com
Office:
310-301-3335
Cell: 424-303-1964
[email protected]